S A Molloy
- Effect of levodopa on cognitive function in Parkinson's disease with and without dementia and dementia with Lewy bodiesS A Molloy
Institute of Ageing and Health, Wolfson Research Centre, Newcastle General Hospital, Newcastle upon Tyne, UK
J Neurol Neurosurg Psychiatry 77:1323-8. 2006..Therefore, the effect of L-dopa on the cognitive profile of dementia with Lewy bodies (DLB) and Parkinson's disease with dementia (PDD) is unclear...
- Reversible delayed posthypoxic leukoencephalopathyS Molloy
Department of Neurology, Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP, England
AJNR Am J Neuroradiol 27:1763-5. 2006..We report a case of reversible delayed posthypoxic/toxic leukoencephalopathy with no clinical or radiologic evidence of gray matter insult...
- Levodopa use and sleep in patients with dementia with Lewy bodiesSophie Molloy
Wolfson Research Centre, Institute for Ageing and Health, Newcastle University, Campus for Ageing and Vitality, Newcastle upon Tyne, United Kingdom
Mov Disord 24:609-12. 2009..Levodopa treatment did not affect sleep or lead to increased EDS in DLB patients. The use of levodopa does not appear to adversely affect subjective sleep measures or increase EDS in DLB patients...